MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
This medicine is a tool, a helping hand to lift you up so you can walk on your own
Whether youre looking to rejuvenate your skin or pamper your body with the latest wellness therapies, medical spas have become a coveted destination for both relaxation [] In todays fast-paced world, prioritizing self-care and aesthetic wellness is no longer just a luxuryits a vital component of maintaining balance and confidence
Planned medical or surgical procedures if you are due to undergo surgery or an invasive procedure, inform both your trial team and the anaesthetic or surgical team
Internal appeal (first level) You have 180 days from the denial date to file an internal appeal